As of 2024-12-13, the Relative Valuation of Santhera Pharmaceuticals Holding AG (SANN.SW) is 80.29 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 9.89 CHF, the upside of Santhera Pharmaceuticals Holding AG based on Relative Valuation is 711.9%.
The range of the Relative Valuation is 65.63 - 196.39 CHF.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 27.2x | 10.0x |
| Forward P/E multiples | 11.1x - 30.4x | 14.0x |
| Fair Price | 65.63 - 196.39 | 80.29 |
| Upside | 563.6% - 1885.7% | 711.9% |
| Date | P/E |
| 2024-12-11 | 1.41 |
| 2024-12-10 | 1.28 |
| 2024-12-09 | 1.18 |
| 2024-12-06 | 1.14 |
| 2024-12-05 | 1.12 |
| 2024-12-04 | 1.17 |
| 2024-12-03 | 1.17 |
| 2024-12-02 | 1.17 |
| 2024-11-29 | 1.17 |
| 2024-11-28 | 1.18 |
| 2024-11-27 | 1.16 |
| 2024-11-26 | 1.19 |
| 2024-11-25 | 1.19 |
| 2024-11-22 | 1.14 |
| 2024-11-21 | 1.12 |
| 2024-11-20 | 1.18 |
| 2024-11-19 | 1.18 |
| 2024-11-18 | 1.14 |
| 2024-11-15 | 1.18 |
| 2024-11-14 | 1.21 |
| 2024-11-13 | 1.20 |
| 2024-11-12 | 1.20 |
| 2024-11-11 | 1.19 |
| 2024-11-08 | 1.23 |
| 2024-11-07 | 1.25 |
| 2024-11-06 | 1.24 |
| 2024-11-05 | 1.26 |
| 2024-11-04 | 1.23 |
| 2024-11-01 | 1.25 |
| 2024-10-31 | 1.23 |
| 2024-10-30 | 1.26 |
| 2024-10-29 | 1.30 |
| 2024-10-28 | 1.30 |
| 2024-10-25 | 1.29 |
| 2024-10-24 | 1.29 |
| 2024-10-23 | 1.28 |
| 2024-10-22 | 1.28 |
| 2024-10-21 | 1.31 |
| 2024-10-18 | 1.31 |
| 2024-10-17 | 1.29 |
| 2024-10-16 | 1.32 |
| 2024-10-15 | 1.29 |
| 2024-10-14 | 1.30 |
| 2024-10-11 | 1.30 |
| 2024-10-10 | 1.32 |
| 2024-10-09 | 1.30 |
| 2024-10-08 | 1.30 |
| 2024-10-07 | 1.31 |
| 2024-10-04 | 1.29 |
| 2024-10-03 | 1.31 |